Institutional investors purchased a net $275.4 thousand shares of TXMD during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 56.23% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
QUANTITATIVE SYSTEMATIC STRATEGI... Bought 78.7 Thousand shares of TherapeuticsMD Inc
INSIDERFONDER AB Bought 5.3 Thousand shares of TherapeuticsMD Inc
J.W. BURNS & CO., INC. (NEW YORK... Sold 12.9 Thousand shares of TherapeuticsMD Inc